Surgeons warn it is too early to recommend a TAVR-first strategy for low-risk patients

[ad_1] One key takeaway from the STS/EACTS statement is that, using the same inclusion criteria found in the PARTNER 3 and Evolut Low Risk trials, SAVR is already associated with…

Cardiologists, cardiac surgeons push insurance company to rethink billing policy

[ad_1] Cardiologists, cardiac surgeons push insurance company to rethink …  Cardiovascular Business [ad_2] Source link

Confirmed: Redo TAVR with balloon-expandable valves is safe and effective

[ad_1] The authors confirmed that the timing of redo TAVR—within one year of the initial procedure or later than one year—did not seem to make a significant impact on mortality…